Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer

BACKGROUND. Intratumoral heterogeneity of (18)F‐fluorodeoxyglucose ((18)F‐FDG) uptake in primary tumor has proven to be a surrogate marker for predicting treatment outcome in various tumors. However, the value of intraindividual heterogeneity in metastatic diseases remains unknown. The aim of this s...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncologist
Главные авторы: Gong, Chengcheng, Ma, Guang, Hu, Xichun, Zhang, Yingjian, Wang, Zhonghua, Zhang, Jian, Zhao, Yannan, Li, Yi, Xie, Yizhao, Yang, Zhongyi, Wang, Biyun
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2018
Предметы:
Breast Cancer
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6263118/
https://ncbi.nlm.nih.gov/pubmed/30082489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы